These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25168563)

  • 1. Re: Zhu et al.: The expression and evaluation of androgen receptor in human renal cell carcinoma (Urology 2014;83:510.e19-24).
    Putz J; Wirth MP; Froehner M; Jahn S
    Urology; 2014 Sep; 84(3):734-5. PubMed ID: 25168563
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply by the authors.
    Zhu G; Li L; He D; Chang C
    Urology; 2014 Sep; 84(3):735. PubMed ID: 25168565
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
    Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
    J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and evaluation of androgen receptor in human renal cell carcinoma.
    Zhu G; Liang L; Li L; Dang Q; Song W; Yeh S; He D; Chang C
    Urology; 2014 Feb; 83(2):510.e19-24. PubMed ID: 24332122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Androgen Receptor Expression with Renal Cell Carcinoma Risk: a Systematic Review and Meta-Analysis.
    Yuan P; Ge Y; Liu X; Wang S; Ye Z; Xu H; Chen Z
    Pathol Oncol Res; 2020 Apr; 26(2):605-614. PubMed ID: 30919276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of androgen, progestin and estrogen receptors with two different assays in renal cell carcinoma.
    Klötzl G; Otto U; Becker H; Klosterhalfen H
    Urol Int; 1987; 42(2):100-4. PubMed ID: 2441503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    J Urol; 2004 Feb; 171(2 Pt 1):611-4. PubMed ID: 14713771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
    Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
    Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
    Nagakura K
    Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.
    Atala A
    J Urol; 2014 Mar; 191(3):866-8. PubMed ID: 24522075
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: microRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
    Kapoor S
    Int J Urol; 2013 Jul; 20(7):739. PubMed ID: 23186135
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
    Turner K
    BJU Int; 2004 Sep; 94(4):678. PubMed ID: 15329141
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
    Laguna MP
    J Urol; 2014 Jan; 191(1):54-5. PubMed ID: 24331469
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
    Guan Z; Li C; Fan J; He D; Li L
    Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-human Chorionic Gonadotropin-producing Renal Cell Carcinoma.
    Adekunle AN; Lam AS; Turbow SD; Stallworth CR; Ferris MJ; Kim J; Jacobson TA
    Am J Med; 2016 Mar; 129(3):e29-31. PubMed ID: 26582059
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinoma.
    Ohba K; Miyata Y; Watanabe S; Hayashi T; Kanetake H; Kanda S; Sakai H
    Anticancer Res; 2011 Feb; 31(2):597-605. PubMed ID: 21378344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR) → c-Myc Signals.
    Atala A
    J Urol; 2016 Jun; 195(6):1947-9. PubMed ID: 27191115
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor.
    Wu Y; Miyamoto T; Li K; Nakagomi H; Sawada N; Kira S; Kobayashi H; Zakohji H; Tsuchida T; Fukazawa M; Araki I; Takeda M
    J Urol; 2011 Dec; 186(6):2419-25. PubMed ID: 22019165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lectin binding studies of the human nephron and renal cell carcinoma].
    Chan YF
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1405-15. PubMed ID: 3807085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical perspectives of metabolomics: the example of renal carcinoma].
    Dormoy V; Massfelder T
    Med Sci (Paris); 2013 May; 29(5):463-8. PubMed ID: 23732093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.